<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Organ Transplantation InstituteShiraz, Iran pmcid: 5549007ijotm-8-104 : Original Article HCV-infected" exact="Renal" post="Transplant Recipients: Our Experience before the Availability of New"/>
 <result pre="infected with HCV in 30 years of activity of a" exact="Renal" post="Transplantation Unit. Methods: We studied 1334 patients who underwent"/>
 <result pre="of the graft. In post-transplantation period, 14 patients developed clinical" exact="hepatic disease," post="10 manifested new-onset diabetes after transplantation, and 4 had"/>
 <result pre="period, 14 patients developed clinical hepatic disease, 10 manifested new-onset" exact="diabetes" post="after transplantation, and 4 had de novo neoplasia, none"/>
 <result pre="and 4 had de novo neoplasia, none of them had" exact="hepatocellular carcinoma." post="The outcomes of the different variables analyzed were similar"/>
 <result pre="10.7–16.1) years; the median survival time of patients without HCV" exact="infection" post="was 14.6 (95% CI: 13.8–15.4) years (p=0.23). Conclusion: In"/>
 <result pre="patient survival as those not infected with HCV. Key Words" exact="Hepatitis" post="C Kidney transplantation Graft rejection Survival Rate Transplant recipients"/>
 <result pre="as those not infected with HCV. Key Words Hepatitis C" exact="Kidney" post="transplantation Graft rejection Survival Rate Transplant recipients Postoperative complications"/>
 <result pre="transplantation Graft rejection Survival Rate Transplant recipients Postoperative complications INTRODUCTION" exact="Hepatitis" post="C virus (HCV) affects approximately 170 million people worldwide;"/>
 <result pre="people worldwide; It is also being a major cause of" exact="end-stage liver disease" post="leading to liver transplantation [1, 2]. The prevalence of"/>
 <result pre="worldwide; It is also being a major cause of end-stage" exact="liver disease" post="leading to liver transplantation [1, 2]. The prevalence of"/>
 <result pre="It is also being a major cause of end-stage liver" exact="disease" post="leading to liver transplantation [1, 2]. The prevalence of"/>
 <result pre="leading to liver transplantation [1, 2]. The prevalence of HCV" exact="infection" post="in patients with chronic kidney disease (CKD) exceeds that"/>
 <result pre="[1, 2]. The prevalence of HCV infection in patients with" exact="chronic" post="kidney disease (CKD) exceeds that in the general population"/>
 <result pre="2]. The prevalence of HCV infection in patients with chronic" exact="kidney disease" post="(CKD) exceeds that in the general population [3]. In"/>
 <result pre="The prevalence of HCV infection in patients with chronic kidney" exact="disease" post="(CKD) exceeds that in the general population [3]. In"/>
 <result pre="major role in the transmission of HCV to patients under" exact="chronic" post="hemodialysis [4]. There has been a noticeable decrease in"/>
 <result pre="hemodialysis [4]. There has been a noticeable decrease in HCV" exact="infection" post="among these patients, however, after the introduction of regular"/>
 <result pre="use of erythropoietin [5]. HCV not only can lead to" exact="kidney disease" post="[6–12], but also contributes to increased morbidity and mortality"/>
 <result pre="of erythropoietin [5]. HCV not only can lead to kidney" exact="disease" post="[6–12], but also contributes to increased morbidity and mortality"/>
 <result pre="increased morbidity and mortality in patients with established CKD [13]." exact="Kidney" post="transplantation is recognized as the renal replacement therapy of"/>
 <result pre="the renal replacement therapy of choice for eligible patients with" exact="end-stage renal disease" post="(ESRD) [14]. Some studies have shown better survival in"/>
 <result pre="renal replacement therapy of choice for eligible patients with end-stage" exact="renal disease" post="(ESRD) [14]. Some studies have shown better survival in"/>
 <result pre="replacement therapy of choice for eligible patients with end-stage renal" exact="disease" post="(ESRD) [14]. Some studies have shown better survival in"/>
 <result pre="[15]. Early detection, prevention, and treatment of complications caused by" exact="chronic" post="HCV infection may improve the outcomes of infected kidney"/>
 <result pre="detection, prevention, and treatment of complications caused by chronic HCV" exact="infection" post="may improve the outcomes of infected kidney transplant recipients"/>
 <result pre="outcomes of infected kidney transplant recipients [16]. Screening for HCV" exact="infection" post="is done using a serological assay that detects antibodies"/>
 <result pre="be performed. A negative result is considered a resolved HCV" exact="infection" post="(or a false-positive antibody test) [17]. Until the introduction"/>
 <result pre="were 1334 kidney transplantations in our center, the António Pina" exact="Renal" post="Transplant Unit. Those with a positive HCV RNA for"/>
 <result pre="the qualitative research of HCV started on 1995 and the" exact="viral" post="load was determined in 1997. The following variables were"/>
 <result pre="humoral), mean serum creatinine at one year, frequency of new-onset" exact="diabetes" post="after transplantation (NODAT), bacteremia, cytomegalovirus infection, cardiovascular events, neoplasia,"/>
 <result pre="one year, frequency of new-onset diabetes after transplantation (NODAT), bacteremia," exact="cytomegalovirus infection," post="cardiovascular events, neoplasia, patient and graft survival in both"/>
 <result pre="frequency of new-onset diabetes after transplantation (NODAT), bacteremia, cytomegalovirus infection," exact="cardiovascular" post="events, neoplasia, patient and graft survival in both groups—with"/>
 <result pre="HCV antibodies were found in 189 recipients; only 60 had" exact="chronic" post="infection, determined by the presence of HCV RNA. Patient"/>
 <result pre="reported in Table 1. Only one patient had pre-transplantation clinical" exact="hepatic disease." post="Table 1 Patient demographics Parameter Statistics HCV-positive recipients 60"/>
 <result pre="DiabetesHypertensionGlomerulonephritisUnknownOthers 2451534 Median (IQR) follow-up (m) 112.3 (109.5–247.0) Pre-transplant clinical" exact="hepatic disease" post="1 HBV co-infection 7 HIV co-infection 0 HCV genotype1A1B234"/>
 <result pre="2451534 Median (IQR) follow-up (m) 112.3 (109.5–247.0) Pre-transplant clinical hepatic" exact="disease" post="1 HBV co-infection 7 HIV co-infection 0 HCV genotype1A1B234"/>
 <result pre="in dialysis was 79 months; only one patient had clinical" exact="liver disease" post="before the transplantation. This patient had HCV and HBV"/>
 <result pre="dialysis was 79 months; only one patient had clinical liver" exact="disease" post="before the transplantation. This patient had HCV and HBV"/>
 <result pre="TAC: tacrolimus,AZA: azathioprine Fourteen (23%) of HCV-infected patients developed clinical" exact="hepatic disease" post="after renal transplantation. Causes of graft failure were chronic"/>
 <result pre="tacrolimus,AZA: azathioprine Fourteen (23%) of HCV-infected patients developed clinical hepatic" exact="disease" post="after renal transplantation. Causes of graft failure were chronic"/>
 <result pre="hepatic disease after renal transplantation. Causes of graft failure were" exact="chronic" post="allograft nephropathy (n=8), vascular or urological problems (n=2), undetermined"/>
 <result pre="after renal transplantation. Causes of graft failure were chronic allograft" exact="nephropathy" post="(n=8), vascular or urological problems (n=2), undetermined (n=8), and"/>
 <result pre="transplantation. Causes of graft failure were chronic allograft nephropathy (n=8)," exact="vascular" post="or urological problems (n=2), undetermined (n=8), and membranous glomerulonephritis"/>
 <result pre="nephropathy (n=8), vascular or urological problems (n=2), undetermined (n=8), and" exact="membranous glomerulonephritis" post="(n=1). Death with a functioning graft (DWFG) occurred in"/>
 <result pre="(n=8), vascular or urological problems (n=2), undetermined (n=8), and membranous" exact="glomerulonephritis" post="(n=1). Death with a functioning graft (DWFG) occurred in"/>
 <result pre="of 318 (IQR: 292–341) months post-transplantation. Causes of DWFG were" exact="infection" post="(n=2), acute liver failure (n=1), and undetermined (n=2). Two"/>
 <result pre="(IQR: 292–341) months post-transplantation. Causes of DWFG were infection (n=2)," exact="acute" post="liver failure (n=1), and undetermined (n=2). Two of the"/>
 <result pre="292–341) months post-transplantation. Causes of DWFG were infection (n=2), acute" exact="liver failure" post="(n=1), and undetermined (n=2). Two of the DWGF developed"/>
 <result pre="(n=1), and undetermined (n=2). Two of the DWGF developed clinical" exact="hepatic disease" post="in the post-transplantation period. Biopsy-proven acute rejection occurred in"/>
 <result pre="and undetermined (n=2). Two of the DWGF developed clinical hepatic" exact="disease" post="in the post-transplantation period. Biopsy-proven acute rejection occurred in"/>
 <result pre="DWGF developed clinical hepatic disease in the post-transplantation period. Biopsy-proven" exact="acute" post="rejection occurred in 10 (17%) patients within the first"/>
 <result pre="Complications during the first year post-transplantation Good initial function 40" exact="Acute" post="tubular necrosis (ATN) 14 Mean±SD duration of ATN (days)"/>
 <result pre="(mg/dL) 1.33 Several other outcomes were of clinical interest. New-onset" exact="diabetes" post="after transplantation occurred in 10 (17%) recipients. Cardiovascular events"/>
 <result pre="Cardiovascular events occurred in 3 (5%) patients. Seven (12%) had" exact="cytomegalovirus infection," post="and four (7%) patients developed neoplasia during the follow-up"/>
 <result pre="developed neoplasia during the follow-up period, none of which was" exact="hepatocellular carcinoma" post="(Table 4). Table 4 Post-transplantation complications Complication n Acute"/>
 <result pre="neoplasia during the follow-up period, none of which was hepatocellular" exact="carcinoma" post="(Table 4). Table 4 Post-transplantation complications Complication n Acute"/>
 <result pre="hepatocellular carcinoma (Table 4). Table 4 Post-transplantation complications Complication n" exact="Acute" post="rejection after the first year CellularHumoral 43 Cardiovascular events"/>
 <result pre="events 3 Neoplasia 4 Bacteriemia 5 Cytomegalovirus 7 Abnormal levels" exact="of liver" post="enzymes 4 NODAT 10 Post-transplantation clinical hepatic disease 14"/>
 <result pre="Abnormal levels of liver enzymes 4 NODAT 10 Post-transplantation clinical" exact="hepatic disease" post="14 Of the seven patients transplanted with HCV and"/>
 <result pre="levels of liver enzymes 4 NODAT 10 Post-transplantation clinical hepatic" exact="disease" post="14 Of the seven patients transplanted with HCV and"/>
 <result pre="years. The median graft survival for those patients without HCV" exact="infection" post="was 14.6 (95% CI: 13.8–15.4) years (p=0.23) (Fig 1)."/>
 <result pre="time of 79 months that could probably explain how they" exact="acquired" post="the infection. Due to the fact that the determination"/>
 <result pre="infection. Due to the fact that the determination of HCV" exact="viral" post="load started only 12 years after the beginning of"/>
 <result pre="excluded some patients from the analysis, because the status of" exact="chronic hepatitis" post="C was unknown. The natural history of the HCV"/>
 <result pre="some patients from the analysis, because the status of chronic" exact="hepatitis" post="C was unknown. The natural history of the HCV"/>
 <result pre="hepatitis C was unknown. The natural history of the HCV" exact="hepatitis" post="in post-renal transplantation has not been well established. Some"/>
 <result pre="well established. Some authors believe that the immunosuppressive therapy facilitates" exact="viral" post="proliferation and aggravates liver disease [19, 20]. However, an"/>
 <result pre="believe that the immunosuppressive therapy facilitates viral proliferation and aggravates" exact="liver disease" post="[19, 20]. However, an increase in viremia may not"/>
 <result pre="that the immunosuppressive therapy facilitates viral proliferation and aggravates liver" exact="disease" post="[19, 20]. However, an increase in viremia may not"/>
 <result pre="in viremia may not be associated with a higher risk" exact="of liver" post="disease after the renal transplantation [21, 22]. Patients with"/>
 <result pre="viremia may not be associated with a higher risk of" exact="liver disease" post="after the renal transplantation [21, 22]. Patients with HCV"/>
 <result pre="may not be associated with a higher risk of liver" exact="disease" post="after the renal transplantation [21, 22]. Patients with HCV"/>
 <result pre="disease after the renal transplantation [21, 22]. Patients with HCV" exact="infection" post="are prone to hepatic and extra-hepatic complications after kidney"/>
 <result pre="complications that our patient developed in the post-transplantation period. HCV" exact="infection" post="is the leading cause of liver disease after kidney"/>
 <result pre="in the post-transplantation period. HCV infection is the leading cause" exact="of liver" post="disease after kidney transplantation and is associated with an"/>
 <result pre="the post-transplantation period. HCV infection is the leading cause of" exact="liver disease" post="after kidney transplantation and is associated with an increase"/>
 <result pre="post-transplantation period. HCV infection is the leading cause of liver" exact="disease" post="after kidney transplantation and is associated with an increase"/>
 <result pre="transplantation and is associated with an increase in mortality [23]." exact="Chronic" post="hepatitis and its sequelae are the main forms of"/>
 <result pre="and is associated with an increase in mortality [23]. Chronic" exact="hepatitis" post="and its sequelae are the main forms of liver"/>
 <result pre="[23]. Chronic hepatitis and its sequelae are the main forms" exact="of liver" post="disease in these patients. HCV-induced cirrhosis is associated with"/>
 <result pre="Chronic hepatitis and its sequelae are the main forms of" exact="liver disease" post="in these patients. HCV-induced cirrhosis is associated with a"/>
 <result pre="hepatitis and its sequelae are the main forms of liver" exact="disease" post="in these patients. HCV-induced cirrhosis is associated with a"/>
 <result pre="the main forms of liver disease in these patients. HCV-induced" exact="cirrhosis" post="is associated with a high risk of hepatocellular carcinoma"/>
 <result pre="patients. HCV-induced cirrhosis is associated with a high risk of" exact="hepatocellular carcinoma" post="[17]. The incidence of hepatocellular carcinoma may be higher"/>
 <result pre="HCV-induced cirrhosis is associated with a high risk of hepatocellular" exact="carcinoma" post="[17]. The incidence of hepatocellular carcinoma may be higher"/>
 <result pre="a high risk of hepatocellular carcinoma [17]. The incidence of" exact="hepatocellular carcinoma" post="may be higher in kidney transplant recipients compared to"/>
 <result pre="high risk of hepatocellular carcinoma [17]. The incidence of hepatocellular" exact="carcinoma" post="may be higher in kidney transplant recipients compared to"/>
 <result pre="[24]. In our sample 14 (23%) HCV-infected patients developed clinical" exact="hepatic disease," post="which was in line with the literature. None had"/>
 <result pre="was in line with the literature. None had progressed to" exact="hepatocellular carcinoma." post="The risk factors that were most consistently associated with"/>
 <result pre="were most consistently associated with progression of fibrosis were severity" exact="of liver" post="disease before transplantation and duration of follow-up after transplantation"/>
 <result pre="most consistently associated with progression of fibrosis were severity of" exact="liver disease" post="before transplantation and duration of follow-up after transplantation [25]."/>
 <result pre="consistently associated with progression of fibrosis were severity of liver" exact="disease" post="before transplantation and duration of follow-up after transplantation [25]."/>
 <result pre="transplantation [25]. In our series, the patients who developed clinical" exact="hepatic disease" post="had longer follow ups. Extra-hepatic complications of HCV infection"/>
 <result pre="[25]. In our series, the patients who developed clinical hepatic" exact="disease" post="had longer follow ups. Extra-hepatic complications of HCV infection"/>
 <result pre="hepatic disease had longer follow ups. Extra-hepatic complications of HCV" exact="infection" post="after renal transplantation include glomerulonephritis, NODAT, infection, and neoplasia."/>
 <result pre="of HCV infection after renal transplantation include glomerulonephritis, NODAT, infection," exact="and neoplasia." post="There is strong epidemiological, clinical, and experimental data linking"/>
 <result pre="neoplasia. There is strong epidemiological, clinical, and experimental data linking" exact="chronic" post="HCV infection to glomerulonephritis in native as well as"/>
 <result pre="is strong epidemiological, clinical, and experimental data linking chronic HCV" exact="infection" post="to glomerulonephritis in native as well as transplanted kidneys"/>
 <result pre="epidemiological, clinical, and experimental data linking chronic HCV infection to" exact="glomerulonephritis" post="in native as well as transplanted kidneys [26-28]. Both"/>
 <result pre="allografts, HCV may cause a variety of glomerular patterns. Membranoproliferative" exact="glomerulonephritis" post="is the most common condition and is sometimes difficult"/>
 <result pre="most common condition and is sometimes difficult to distinguish from" exact="chronic" post="allograft nephropathy. Eight of the 19 lost allografts in"/>
 <result pre="19 lost allografts in our series had histological evidence of" exact="chronic" post="allograft nephropathy. The role of HCV is uncertain in"/>
 <result pre="study lost his graft due to glomerulopathy, specifically de novo" exact="membranous glomerulonephritis," post="which also can be linked to the virus. HCV"/>
 <result pre="glomerulonephritis, which also can be linked to the virus. HCV" exact="infection" post="has been associated with insulin resistance [29, 30], and"/>
 <result pre="infection has been associated with insulin resistance [29, 30], and" exact="diabetes mellitus" post="in the general population [31-33]. Some authors have shown"/>
 <result pre="in the general population [31-33]. Some authors have shown that" exact="chronic" post="HCV infection is an independent risk factor for NODAT"/>
 <result pre="general population [31-33]. Some authors have shown that chronic HCV" exact="infection" post="is an independent risk factor for NODAT as well,"/>
 <result pre="Several early studies found a significantly increased risk for other" exact="infections" post="in HCV-infected recipients [34-36], with the highest risk in"/>
 <result pre="study. A meta-analysis found a 5.7-fold increase in risk for" exact="non-Hodgkin lymphoma" post="in HCV-infected patients [37]. Four of our patients developed"/>
 <result pre="A meta-analysis found a 5.7-fold increase in risk for non-Hodgkin" exact="lymphoma" post="in HCV-infected patients [37]. Four of our patients developed"/>
 <result pre="patients developed neoplasia post-transplantation, but none of them had developed" exact="lymphoma" post="or hepatocellular carcinoma. In this miscellaneous group of patients"/>
 <result pre="neoplasia post-transplantation, but none of them had developed lymphoma or" exact="hepatocellular carcinoma." post="In this miscellaneous group of patients transplanted from 1985"/>
 <result pre="time of the graft in the control group without HCV" exact="infection" post="was 14.6 (95% CI: 13.8–15.4) years, p=0.23. In conclusion,"/>
 <result pre="was 14.6 (95% CI: 13.8–15.4) years, p=0.23. In conclusion, HCV" exact="infection" post="has long been recognized as the main liver disease"/>
 <result pre="conclusion, HCV infection has long been recognized as the main" exact="liver disease" post="in kidney transplantation. Despite the lack of efficacious and"/>
 <result pre="HCV infection has long been recognized as the main liver" exact="disease" post="in kidney transplantation. Despite the lack of efficacious and"/>
 <result pre="of a cDNA clone derived from a blood-borne non-A, non-B" exact="viral hepatitis" post="genome Science1989244359622523562 2AlterHJSeeffLBRecovery, persistence, and sequelae in hepatitis C"/>
 <result pre="a cDNA clone derived from a blood-borne non-A, non-B viral" exact="hepatitis" post="genome Science1989244359622523562 2AlterHJSeeffLBRecovery, persistence, and sequelae in hepatitis C"/>
 <result pre="non-B viral hepatitis genome Science1989244359622523562 2AlterHJSeeffLBRecovery, persistence, and sequelae in" exact="hepatitis" post="C virus infection: A perspective on long-term outcome Semin"/>
 <result pre="A perspective on long-term outcome Semin Liver Dis200020173510895429 3TsuiJIVittinghoffEShlipakMGO’HareAMRelationship between" exact="hepatitis" post="C and chronic kidney disease: Results from the Third"/>
 <result pre="long-term outcome Semin Liver Dis200020173510895429 3TsuiJIVittinghoffEShlipakMGO’HareAMRelationship between hepatitis C and" exact="chronic" post="kidney disease: Results from the Third National Health and"/>
 <result pre="J Am Soc Nephrol20061711687416524948 4DenewarAAMonemEl-Hendy YAWafaEWet al.The Long-Term Effect of" exact="Hepatitis" post="C Virus on the Outcome of Live-Donor Kidney Transplant"/>
 <result pre="Effect of Hepatitis C Virus on the Outcome of Live-Donor" exact="Kidney" post="Transplant Recipients. A Retrospective Study Exp Clin Transplant201513402726450463 5EinollahiBAlavianSMHepatitis"/>
 <result pre="Transplant Recipients. A Retrospective Study Exp Clin Transplant201513402726450463 5EinollahiBAlavianSMHepatitis C" exact="virus infection" post="and kidney transplantation: a review for clinicians Iran J"/>
 <result pre="Recipients. A Retrospective Study Exp Clin Transplant201513402726450463 5EinollahiBAlavianSMHepatitis C virus" exact="infection" post="and kidney transplantation: a review for clinicians Iran J"/>
 <result pre="infection and kidney transplantation: a review for clinicians Iran J" exact="Kidney" post="Dis201041820081297 6PereiraBJLeveyASHepatitis C virus infection in dialysis and renal"/>
 <result pre="a review for clinicians Iran J Kidney Dis201041820081297 6PereiraBJLeveyASHepatitis C" exact="virus infection" post="in dialysis and renal transplantation Kidney Int199751981999083262 7DalrympleLSKoepsellTSampsonJet al.Hepatitis"/>
 <result pre="review for clinicians Iran J Kidney Dis201041820081297 6PereiraBJLeveyASHepatitis C virus" exact="infection" post="in dialysis and renal transplantation Kidney Int199751981999083262 7DalrympleLSKoepsellTSampsonJet al.Hepatitis"/>
 <result pre="Dis201041820081297 6PereiraBJLeveyASHepatitis C virus infection in dialysis and renal transplantation" exact="Kidney" post="Int199751981999083262 7DalrympleLSKoepsellTSampsonJet al.Hepatitis C virus infection and the prevalence"/>
 <result pre="in dialysis and renal transplantation Kidney Int199751981999083262 7DalrympleLSKoepsellTSampsonJet al.Hepatitis C" exact="virus infection" post="and the prevalence of renal insufficiency Clin J Am"/>
 <result pre="dialysis and renal transplantation Kidney Int199751981999083262 7DalrympleLSKoepsellTSampsonJet al.Hepatitis C virus" exact="infection" post="and the prevalence of renal insufficiency Clin J Am"/>
 <result pre="Int199751981999083262 7DalrympleLSKoepsellTSampsonJet al.Hepatitis C virus infection and the prevalence of" exact="renal insufficiency" post="Clin J Am Soc Nephrol200727152117699487 8FabriziF1PozziCFarinaMet al.Hepatitis C virus"/>
 <result pre="renal insufficiency Clin J Am Soc Nephrol200727152117699487 8FabriziF1PozziCFarinaMet al.Hepatitis C" exact="virus infection" post="and acute or chronic glomerulonephritis: An epidemiological and clinical"/>
 <result pre="insufficiency Clin J Am Soc Nephrol200727152117699487 8FabriziF1PozziCFarinaMet al.Hepatitis C virus" exact="infection" post="and acute or chronic glomerulonephritis: An epidemiological and clinical"/>
 <result pre="J Am Soc Nephrol200727152117699487 8FabriziF1PozziCFarinaMet al.Hepatitis C virus infection and" exact="acute" post="or chronic glomerulonephritis: An epidemiological and clinical appraisal Nephrol"/>
 <result pre="Am Soc Nephrol200727152117699487 8FabriziF1PozziCFarinaMet al.Hepatitis C virus infection and acute" exact="or chronic" post="glomerulonephritis: An epidemiological and clinical appraisal Nephrol Dial Transplant199813199179719153"/>
 <result pre="Soc Nephrol200727152117699487 8FabriziF1PozziCFarinaMet al.Hepatitis C virus infection and acute or" exact="chronic" post="glomerulonephritis: An epidemiological and clinical appraisal Nephrol Dial Transplant199813199179719153"/>
 <result pre="multifaceted disease. Reviewof extrahepatic manifestations Ann Intern Med1995123615207677303 10JohnsonRJGretchDRYamabeHet al.Membranoproliferative" exact="glomerulonephritis" post="associated with hepatitis C virus infection N Engl J"/>
 <result pre="extrahepatic manifestations Ann Intern Med1995123615207677303 10JohnsonRJGretchDRYamabeHet al.Membranoproliferative glomerulonephritis associated with" exact="hepatitis" post="C virus infection N Engl J Med1993328465707678440 11D’AmicoGRenal involvement"/>
 <result pre="Ann Intern Med1995123615207677303 10JohnsonRJGretchDRYamabeHet al.Membranoproliferative glomerulonephritis associated with hepatitis C" exact="virus infection" post="N Engl J Med1993328465707678440 11D’AmicoGRenal involvement in hepatitis C"/>
 <result pre="Intern Med1995123615207677303 10JohnsonRJGretchDRYamabeHet al.Membranoproliferative glomerulonephritis associated with hepatitis C virus" exact="infection" post="N Engl J Med1993328465707678440 11D’AmicoGRenal involvement in hepatitis C"/>
 <result pre="C virus infection N Engl J Med1993328465707678440 11D’AmicoGRenal involvement in" exact="hepatitis" post="C infection: Cryoglobulinemic glomerulonephritis Kidney Int199854650719690235 12SabryAASobhMAIrvingWLet al.A comprehensive"/>
 <result pre="Engl J Med1993328465707678440 11D’AmicoGRenal involvement in hepatitis C infection: Cryoglobulinemic" exact="glomerulonephritis" post="Kidney Int199854650719690235 12SabryAASobhMAIrvingWLet al.A comprehensive study of the association"/>
 <result pre="J Med1993328465707678440 11D’AmicoGRenal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis" exact="Kidney" post="Int199854650719690235 12SabryAASobhMAIrvingWLet al.A comprehensive study of the association between"/>
 <result pre="Kidney Int199854650719690235 12SabryAASobhMAIrvingWLet al.A comprehensive study of the association between" exact="hepatitis" post="C virus and glomerulopathy Nephrol Dial Transplant2002172394511812873 13RothD1GaynorJJReddyKRet al.Effect"/>
 <result pre="C virus and glomerulopathy Nephrol Dial Transplant2002172394511812873 13RothD1GaynorJJReddyKRet al.Effect of" exact="Kidney" post="Transplantation on Outcomes among Patients with Hepatitis C J"/>
 <result pre="13RothD1GaynorJJReddyKRet al.Effect of Kidney Transplantation on Outcomes among Patients with" exact="Hepatitis" post="C J Am Soc Nephrol201122115260doi: 10.1681/ASN.2010060668. Epub 2011 May"/>
 <result pre="of immunosuppressive regimen on survival of kidney transplant recipients with" exact="hepatitis" post="C Transplantation2008851601618551066 16TangIYWalzerNAggarwalNet al.Management of the kidney transplant patient"/>
 <result pre="C Transplantation2008851601618551066 16TangIYWalzerNAggarwalNet al.Management of the kidney transplant patient with" exact="chronic hepatitis" post="C infection Int J Nephrol20112011245823doi: 10.4061/2011/245823. Epub 2011 Apr"/>
 <result pre="Transplantation2008851601618551066 16TangIYWalzerNAggarwalNet al.Management of the kidney transplant patient with chronic" exact="hepatitis" post="C infection Int J Nephrol20112011245823doi: 10.4061/2011/245823. Epub 2011 Apr"/>
 <result pre="al.Management of the kidney transplant patient with chronic hepatitis C" exact="infection" post="Int J Nephrol20112011245823doi: 10.4061/2011/245823. Epub 2011 Apr 2621603155 17Baid-AgrawalSPascualMMoradpourDet"/>
 <result pre="J Nephrol20112011245823doi: 10.4061/2011/245823. Epub 2011 Apr 2621603155 17Baid-AgrawalSPascualMMoradpourDet al.Hepatitis C" exact="virus infection" post="and kidney transplantation in 2014: what’s new? Am J"/>
 <result pre="Nephrol20112011245823doi: 10.4061/2011/245823. Epub 2011 Apr 2621603155 17Baid-AgrawalSPascualMMoradpourDet al.Hepatitis C virus" exact="infection" post="and kidney transplantation in 2014: what’s new? Am J"/>
 <result pre="new? Am J Transplant201414220620doi: 10.1111/ajt.12835. Epub 2014 Aug 425091274 18SperlJFrankováSSpicákJ[Viral" exact="hepatitis" post="in immunosuppressed patients] Klin Mikrobiol Infekc Lek201016120123[in Czech]20809462 19MangaSahin"/>
 <result pre="Klin Mikrobiol Infekc Lek201016120123[in Czech]20809462 19MangaSahin GSahinSKantarciGErgin H Impact of" exact="Hepatitis" post="C Virus Infection on Patient and Graft Survival in"/>
 <result pre="Lek201016120123[in Czech]20809462 19MangaSahin GSahinSKantarciGErgin H Impact of Hepatitis C Virus" exact="Infection" post="on Patient and Graft Survival in Kidney Transplantation Transplant"/>
 <result pre="Hepatitis C Virus Infection on Patient and Graft Survival in" exact="Kidney" post="Transplantation Transplant Proc20063849950116549159 20PedrosoSMartinsLFonsecaIet al.Impact of Hepatits C Virus"/>
 <result pre="Transplantation Transplant Proc20063849950116549159 20PedrosoSMartinsLFonsecaIet al.Impact of Hepatits C Virus on" exact="Renal" post="Transplantation: Association with Poor Survival Transplant Proc2006381890416908314 21CorrêaJRRochaFDPeresAAet al.[Long"/>
 <result pre="with Poor Survival Transplant Proc2006381890416908314 21CorrêaJRRochaFDPeresAAet al.[Long Term Effect of" exact="Hepatitis" post="B and C Virus on the Survival of Kidney"/>
 <result pre="of Hepatitis B and C Virus on the Survival of" exact="Kidney" post="Transplant Patients]Rev Assoc Med Bras (1992)20034938994Epub 2004 Feb 4."/>
 <result pre="Feb 4. [in Portuguese]14963590 22MoralesJMCampistolJMCampistol. Transplantation in the Patient with" exact="Hepatitis" post="C J Am Soc Nephrol20001113435310864593 23Baid-AgrawalSPascualMMoradpourDet al.Hepatitis C virus"/>
 <result pre="with Hepatitis C J Am Soc Nephrol20001113435310864593 23Baid-AgrawalSPascualMMoradpourDet al.Hepatitis C" exact="virus infection" post="in haemodialysis and kidney transplant patients Rev Med Virol2008189711518064722"/>
 <result pre="Hepatitis C J Am Soc Nephrol20001113435310864593 23Baid-AgrawalSPascualMMoradpourDet al.Hepatitis C virus" exact="infection" post="in haemodialysis and kidney transplant patients Rev Med Virol2008189711518064722"/>
 <result pre="haemodialysis and kidney transplant patients Rev Med Virol2008189711518064722 24RidruejoEMandoOGDavalosMet al.Hepatocellular" exact="carcinoma" post="in renal transplant patients Transplant Proc2005372086815964346 25KamarNRostaingLSelvesJet al.Natural history"/>
 <result pre="in renal transplant patients Transplant Proc2005372086815964346 25KamarNRostaingLSelvesJet al.Natural history of" exact="hepatitis" post="C virus-related liver fibrosis after renal transplantation Am J"/>
 <result pre="patients Transplant Proc2005372086815964346 25KamarNRostaingLSelvesJet al.Natural history of hepatitis C virus-related" exact="liver fibrosis" post="after renal transplantation Am J Transplant2005517041215943629 26BaidSCosimiABTolkoff-RubinNet al.Renal disease"/>
 <result pre="liver fibrosis after renal transplantation Am J Transplant2005517041215943629 26BaidSCosimiABTolkoff-RubinNet al.Renal" exact="disease" post="associated with hepatitis C infection after kidney and liver"/>
 <result pre="renal transplantation Am J Transplant2005517041215943629 26BaidSCosimiABTolkoff-RubinNet al.Renal disease associated with" exact="hepatitis" post="C infection after kidney and liver transplantation Transplantation2000702556110933143 27CruzadoJMBestardOGrinyoJMImpact"/>
 <result pre="Am J Transplant2005517041215943629 26BaidSCosimiABTolkoff-RubinNet al.Renal disease associated with hepatitis C" exact="infection" post="after kidney and liver transplantation Transplantation2000702556110933143 27CruzadoJMBestardOGrinyoJMImpact of extrahepatic"/>
 <result pre="Transplantation2000702556110933143 27CruzadoJMBestardOGrinyoJMImpact of extrahepatic complications (diabetes and glomerulonephritis) associated with" exact="hepatitis" post="C virus infection after renal transplantation Contrib Nephrol20121761081622310786 28TangSCLaiKNHepatitis"/>
 <result pre="of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C" exact="virus infection" post="after renal transplantation Contrib Nephrol20121761081622310786 28TangSCLaiKNHepatitis C virus-associated glomerulonephritis"/>
 <result pre="extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus" exact="infection" post="after renal transplantation Contrib Nephrol20121761081622310786 28TangSCLaiKNHepatitis C virus-associated glomerulonephritis"/>
 <result pre="virus infection after renal transplantation Contrib Nephrol20121761081622310786 28TangSCLaiKNHepatitis C virus-associated" exact="glomerulonephritis" post="Contrib Nephrol201318119420623689581 29MilnerKLvander Poorten DTrenellMet al.Chronic hepatitis C is"/>
 <result pre="28TangSCLaiKNHepatitis C virus-associated glomerulonephritis Contrib Nephrol201318119420623689581 29MilnerKLvander Poorten DTrenellMet al.Chronic" exact="hepatitis" post="C is associated with peripheral rather than hepatic insulin"/>
 <result pre="Nephrol201318119420623689581 29MilnerKLvander Poorten DTrenellMet al.Chronic hepatitis C is associated with" exact="peripheral" post="rather than hepatic insulin resistance Gastroenterology201013893241e1-3. doi: 10.1053/j.gastro.2009.11.050. Epub"/>
 <result pre="doi: 10.1053/j.gastro.2009.11.050. Epub 2009 Dec 4.19962985 30MoucariRAsselahTCazals-HatemDet al.Insulin resistance in" exact="chronic hepatitis" post="C: Association with genotypes 1 and 4, serum HCV"/>
 <result pre="10.1053/j.gastro.2009.11.050. Epub 2009 Dec 4.19962985 30MoucariRAsselahTCazals-HatemDet al.Insulin resistance in chronic" exact="hepatitis" post="C: Association with genotypes 1 and 4, serum HCV"/>
 <result pre="serum HCV RNA level, and liver fibrosis200813441623 31MehtaSHBrancatiFLSulkowskiMSet al.Prevalence of" exact="type 2" post="diabetes mellitus among persons with hepatitis C virus infection"/>
 <result pre="RNA level, and liver fibrosis200813441623 31MehtaSHBrancatiFLSulkowskiMSet al.Prevalence of type 2" exact="diabetes mellitus" post="among persons with hepatitis C virus infection in the"/>
 <result pre="31MehtaSHBrancatiFLSulkowskiMSet al.Prevalence of type 2 diabetes mellitus among persons with" exact="hepatitis" post="C virus infection in the United States Ann Intern"/>
 <result pre="of type 2 diabetes mellitus among persons with hepatitis C" exact="virus infection" post="in the United States Ann Intern Med2000133592911033586 32ZeinCOLevyCBasuAZeinNNChronic hepatitis"/>
 <result pre="type 2 diabetes mellitus among persons with hepatitis C virus" exact="infection" post="in the United States Ann Intern Med2000133592911033586 32ZeinCOLevyCBasuAZeinNNChronic hepatitis"/>
 <result pre="virus infection in the United States Ann Intern Med2000133592911033586 32ZeinCOLevyCBasuAZeinNNChronic" exact="hepatitis" post="C and type II diabetes mellitus: A prospective cross-sectional"/>
 <result pre="the United States Ann Intern Med2000133592911033586 32ZeinCOLevyCBasuAZeinNNChronic hepatitis C and" exact="type II" post="diabetes mellitus: A prospective cross-sectional study Am J Gastroenterol2005100485515654780"/>
 <result pre="States Ann Intern Med2000133592911033586 32ZeinCOLevyCBasuAZeinNNChronic hepatitis C and type II" exact="diabetes" post="mellitus: A prospective cross-sectional study Am J Gastroenterol2005100485515654780 33WhiteDLRatziuVEl-SeragHBHepatitis"/>
 <result pre="mellitus: A prospective cross-sectional study Am J Gastroenterol2005100485515654780 33WhiteDLRatziuVEl-SeragHBHepatitis C" exact="infection" post="and risk of diabetes: A systematic review and meta-analysis"/>
 <result pre="systematic review and meta-analysis J Hepatol2008498314418814931 34PereiraBJWrightTLSchmidCHLeveyASThe impact of pretransplantation" exact="hepatitis" post="C infection on the outcome of renal transplantation Transplantation1995607998057482738"/>
 <result pre="and meta-analysis J Hepatol2008498314418814931 34PereiraBJWrightTLSchmidCHLeveyASThe impact of pretransplantation hepatitis C" exact="infection" post="on the outcome of renal transplantation Transplantation1995607998057482738 35RaoKVMaJChronic viral"/>
 <result pre="C infection on the outcome of renal transplantation Transplantation1995607998057482738 35RaoKVMaJChronic" exact="viral hepatitis" post="enhances the risk of infection but not acute rejection"/>
 <result pre="infection on the outcome of renal transplantation Transplantation1995607998057482738 35RaoKVMaJChronic viral" exact="hepatitis" post="enhances the risk of infection but not acute rejection"/>
 <result pre="renal transplantation Transplantation1995607998057482738 35RaoKVMaJChronic viral hepatitis enhances the risk of" exact="infection" post="but not acute rejection in renal transplant recipients Transplantation199662176598990359"/>
 <result pre="35RaoKVMaJChronic viral hepatitis enhances the risk of infection but not" exact="acute" post="rejection in renal transplant recipients Transplantation199662176598990359 36RothDZuckerKCiroccoRet al.The impact"/>
 <result pre="rejection in renal transplant recipients Transplantation199662176598990359 36RothDZuckerKCiroccoRet al.The impact of" exact="hepatitis" post="C virus infection on renal allograft recipients Kidney Int199445238447510350"/>
 <result pre="renal transplant recipients Transplantation199662176598990359 36RothDZuckerKCiroccoRet al.The impact of hepatitis C" exact="virus infection" post="on renal allograft recipients Kidney Int199445238447510350 37MatsuoKKusanoASugumarAet al.Effect of"/>
 <result pre="transplant recipients Transplantation199662176598990359 36RothDZuckerKCiroccoRet al.The impact of hepatitis C virus" exact="infection" post="on renal allograft recipients Kidney Int199445238447510350 37MatsuoKKusanoASugumarAet al.Effect of"/>
 <result pre="impact of hepatitis C virus infection on renal allograft recipients" exact="Kidney" post="Int199445238447510350 37MatsuoKKusanoASugumarAet al.Effect of hepatitis C virus infection on"/>
 <result pre="infection on renal allograft recipients Kidney Int199445238447510350 37MatsuoKKusanoASugumarAet al.Effect of" exact="hepatitis" post="C virus infection on the risk of non-Hodgkin’s lymphoma:"/>
 <result pre="renal allograft recipients Kidney Int199445238447510350 37MatsuoKKusanoASugumarAet al.Effect of hepatitis C" exact="virus infection" post="on the risk of non-Hodgkin’s lymphoma: A meta-analysis of"/>
 <result pre="allograft recipients Kidney Int199445238447510350 37MatsuoKKusanoASugumarAet al.Effect of hepatitis C virus" exact="infection" post="on the risk of non-Hodgkin’s lymphoma: A meta-analysis of"/>
 <result pre="the risk of non-Hodgkin’s lymphoma: A meta-analysis of epidemiological studies" exact="Cancer" post="Sci2004957455215471561"/>
</results>
